article thumbnail

Why is microbiological testing in medical device manufacturing important?

European Pharmaceutical Review

This approach can also help determine the appropriate manufacturing processes, sterilisation methods, and maintenance procedures. However, the safety and efficacy of these devices can be compromised if they are not appropriately designed, manufactured, and maintained, the authors wrote. Sharma et al.

article thumbnail

AMR certification: recognising responsibly in antibiotic manufacture

European Pharmaceutical Review

On 6 June 2023, the British Standards Institute (BSI) launched its Minimized Risk of Antimicrobial Resistance (AMR) certification for antibiotic manufacturing. Soulsby and Brooks explain what the new certification means for antibiotic manufacturers and the wider pharma industry, and its anticipated benefit for supply chain sustainability.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

A market report has projected that the global oral solid dosage (OSD) contract manufacturing market is expected to be worth $54.7 Data showed that worldwide, oral solids are the most popular mode of drug delivery due to being highly cost-effective and offering simple manufacturing processes.

article thumbnail

Oragenics secures CQDM funding for Covid-19 vaccine antigen development

Pharmaceutical Technology

Using the advanced manufacturing platform of NRC, these vaccine antigens are expected to be quickly deployable in next-generation vaccine formulations. NRC’s platform was developed for the reference strain SARS-CoV-2 spike antigen. “Our

article thumbnail

Making the Case for Case Management for Cell and Gene Therapies

As demand for advanced therapies increases, so does the need for more specialized supply chain support, as these products have strict transportation and handling requirements. It is crucial to ensure supply chain risks are mitigated and have proactive strategies in place to address unforeseen challenges before they become an issue.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What are the top three supply-related challenges facing pharmaceutical manufacturers?

article thumbnail

GSK requires supplier sustainability compliance from 2023

European Pharmaceutical Review

Moreover, pharmaceutical manufacturing poses a huge detriment to the state of the planet’s ecosystem. Under the Sustainable Procurement Programme, every aspect of the supply chain is required to take action on carbon, power , heat, transport, water, waste, and sustainable and deforestation-free sourcing of materials.